Verve Therapeutics Reports Durable and Well-Tolerated Editing of[...]
Verve Therapeutics to Participate in Upcoming May Investor Conferences
Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid[...]
01/27/2022 | News release | Distributed by Public on 01/27/2022 06:13
Please select the service you want to use:
Smartlinks | Wiggle Ltd. | News | Technology | Internet | Company News | Private Companies | E-Commerce Companies
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact